CORPAY, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CORPAY, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.53B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.97B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $3.76B | Feb 27, 2026 |
| FY2023 | Sep 30, 2023 | $970.89M | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $948.17M | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $901.33M | Feb 29, 2024 |
| FY2024 | Dec 31, 2022 | $3.43B | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | $802.26M | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | $755.48M | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | $667.38M | Mar 1, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $609.99M | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $577.88M | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $541.24M | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $520.43M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $514.95M | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $484.43M | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $417.91M | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $414.26M | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $430.60M | Mar 1, 2017 |
| FY2016 | Sep 30, 2015 | $451.49M | Mar 1, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.07B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.00B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $981.89M | Feb 27, 2026 |
| FY2023 | Sep 30, 2023 | $271.50M | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $239.70M | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $214.84M | Feb 29, 2024 |
| FY2024 | Dec 31, 2022 | $954.33M | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | $225.00M | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | $234.01M | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | $196.25M | Mar 1, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.99B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.79B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.66B | Feb 27, 2026 |
| FY2023 | Sep 30, 2023 | $444.98M | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $412.65M | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $375.20M | Feb 29, 2024 |
| FY2024 | Dec 31, 2022 | $1.45B | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | $340.29M | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | $338.69M | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | $297.61M | Mar 1, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.50B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.94B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $2.10B | Feb 27, 2026 |
| FY2023 | Sep 30, 2023 | $1.38B | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $1.10B | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $877.67M | Feb 29, 2024 |
| FY2024 | Dec 31, 2022 | $754.80M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.20B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.47B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.16B | Mar 1, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $200.76M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $175.18M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $153.82M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $151.43M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $111.53M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $78.43M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $75.17M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $81.39M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $70.09M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $59.01M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.41B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $17.96B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $15.48B | Feb 27, 2025 |
| FY2023 | Sep 30, 2023 | $15.67B | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $15.44B | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $15.14B | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $14.09B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $13.40B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $11.19B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $12.25B | Feb 26, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.88B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $3.12B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $3.28B | Feb 27, 2025 |
| FY2023 | Sep 30, 2023 | $3.06B | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $3.26B | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $2.88B | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $2.54B | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $2.87B | Feb 29, 2024 |
| FY2023 | Dec 31, 2020 | $3.36B | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $3.71B | Feb 28, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.56B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $5.98B | Feb 27, 2026 |
| FY2024 | Oct 1, 2024 | $57.00M | Feb 27, 2025 |
| FY2025 | Dec 31, 2023 | $5.64B | Feb 27, 2026 |
| FY2023 | Sep 30, 2023 | $5.55B | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $5.47B | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $5.38B | Feb 29, 2024 |
| FY2024 | Dec 31, 2022 | $5.20B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $5.08B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $4.72B | Feb 28, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.26B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $9.20B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $8.19B | Feb 27, 2025 |
| FY2023 | Sep 30, 2023 | $7.94B | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | $7.67B | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | $7.43B | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $7.21B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $6.26B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $5.42B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $4.71B | Feb 26, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.41B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.55B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.39B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.44B | Feb 27, 2025 |
| FY2022 | Dec 31, 2021 | $1.52B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $934.90M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.27B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.03B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $913.60M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $475.02M | Mar 1, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.00B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $8.00B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $6.72B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $7.04B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $5.98B | Feb 28, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 14 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 13 | Feb 27, 2026 |
| FY2023 | Sep 30, 2023 | 3 | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | 3 | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | 2 | Feb 29, 2024 |
| FY2024 | Dec 31, 2022 | 12 | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | 2 | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | 2 | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | 2 | Mar 1, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 13 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 13 | Feb 27, 2026 |
| FY2023 | Sep 30, 2023 | 3 | Feb 29, 2024 |
| FY2023 | Jun 30, 2023 | 3 | Feb 29, 2024 |
| FY2023 | Mar 31, 2023 | 2 | Feb 29, 2024 |
| FY2024 | Dec 31, 2022 | 12 | Feb 27, 2025 |
| FY2021 | Dec 31, 2021 | 2 | Mar 1, 2022 |
| FY2021 | Sep 30, 2021 | 2 | Mar 1, 2022 |
| FY2021 | Jun 30, 2021 | 2 | Mar 1, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 68.36M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 70.17M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 71.72M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 73.36M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 78.88M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 83.67M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 85.34M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 85.85M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 89.80M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 91.84M | Mar 1, 2018 |